Heart monitor after ablation may cut AF time

NCT ID NCT04922281

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using an implantable heart monitor (or a wearable patch) to detect atrial fibrillation early after catheter ablation can reduce the total time spent in AF. About 120 people with paroxysmal or persistent AF will be monitored for 15 months. The goal is to see if early treatment guided by the monitor lowers AF burden and healthcare use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Insertable cardiac monitor (Confirm Rx) or external LT-ECG patch (CAM)
What this could lead to
If successful, this could show that early detection and treatment of atrial fibrillation after ablation reduces the total time spent in AF, improving heart health.
What could go wrong
This is a small, early-phase study with only 120 participants, so results may not apply to everyone. The monitoring devices may cause discomfort or skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.